Renovis Inc - Current report filing (8-K)
April 03 2008 - 5:11PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): April 3, 2008
RENOVIS, INC.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
000-50564
|
|
94-3353740
|
(State or other jurisdiction
of incorporation)
|
|
(Commission File Number)
|
|
(I.R.S. Employer
Identification No.)
|
Two Corporate Drive
San Francisco, California 94080
(Address of Principal Executive Offices)
(650) 266-1400
(Registrants telephone number, including area code)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (
see
General Instruction A.2. below):
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
x
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
On April 3, 2008, Renovis, Inc.
(Renovis) and Evotec AG (Evotec) announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, has expired without the United States Federal Trade Commission requesting
additional information with regard to the proposed Agreement and Plan of Merger, dated September 18, 2007, by and between Evotec and Renovis, as amended to date (the Merger Agreement).
The companies anticipate that the transaction, which remains subject to the approval of Renoviss stockholders and other customary closing
conditions, will close in early May, 2008.
The press release is attached hereto as an exhibit and is incorporated by reference herein.
Forward-Looking Statements
This
communication contains certain forward-looking statements. These forward-looking statements, which may include, but are not limited to, statements concerning the anticipated timing of the closing of the transaction, are based on managements
current expectations and estimates and involve risks and uncertainties that could cause actual results or outcomes to differ materially from those contemplated by the forward-looking statements.
Factors that could cause or contribute to such differences may include, but are not limited to, the risk that the conditions relating to the required
regulatory clearance might not be satisfied in a timely manner or at all, risks relating to the integration of the technologies and businesses of Evotec and Renovis, unanticipated expenditures, changing relationships with customers, suppliers and
strategic partners, conditions of the economy and other factors described in the Registration Statement on Form F-4 filed with the SEC by Evotec and the most recent reports on Form 10-K, Form 10-Q, Form 8-K and other periodic reports filed by
Renovis with the SEC.
Item 9.01.
|
Financial Statements and Exhibits.
|
|
|
|
99.1
|
|
Press Release of Renovis dated April 3, 2008.
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
|
|
RENOVIS, INC.
|
|
|
|
|
Date: April 3, 2008
|
|
|
|
By
|
|
/s/ Jeffrey S. Farrow
|
|
|
|
|
|
|
Name:
|
|
Jeffrey S. Farrow
|
|
|
|
|
|
|
Title:
|
|
Vice President of Finance and Chief Accounting Officer
|
Exhibit Index
|
|
|
Exhibit No.
|
|
Description
|
99.1
|
|
Press Release of Renovis dated April 3, 2008.
|
Renovis (MM) (NASDAQ:RNVS)
Historical Stock Chart
From Sep 2024 to Oct 2024
Renovis (MM) (NASDAQ:RNVS)
Historical Stock Chart
From Oct 2023 to Oct 2024